{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:48:39Z","timestamp":1793296119921,"version":"4.5.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Object<\/jats:title><jats:p>The hepatitis C virus (HCV) is prevalent across China, with a distinctive genotypic distribution that varies by geographical region and mode of transmission. Yunnan is one such geographical region wherein the local population continues to experience a high level of HCV infection, severely straining public health resources. This high prevalence is likely due to the increased incidence of intravenous drug use in that region, as Yunnan is a major point of entry for illegal heroin into China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated 510 individuals with chronic HCV infections in Yunnan Province from 2008 through 2018. Using reverse transcription PCR and Sanger sequencing to amplify and sequence samples. Bayesian analyses was performed to estimate the common ancestors and Bayesian skyline plot to estimate the effective viral population size. Molecular network was conducted to explore the characteristics of HCV transmission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We successfully amplified and sequenced a total of 503 viral samples and genotyped each as either 3b (37.6%), 3a (21.9%), 1b (19.3%), 2a (10.5%), HCV-6 (10.1%), or 1a (0.6%). Over this 11-year period, we observed that the proportion of 3a and 3b subtypes markedly increased and, concomitantly, that the proportion of 1b and 2a subtypes decreased. We also performed Bayesian analyses to estimate the common ancestors of the four major subtypes, 1b, 2a, 3a, and 3b. Finally, we determined that our Bayesian skyline plot and transmission network data correlated well with the changes we observed in the proportions of HCV subtypes over time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Taken together, our results indicate that the prevalence of HCV 3a and 3b subtypes is rapidly increasing in Yunnan, thus demonstrating a steadily growing public health requirement to implement more stringent preventative and therapeutic measures to curb the spread of the virus.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1092936","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T05:12:15Z","timestamp":1689052335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008\u20132018"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuanyuan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.2147\/IDR.S385071","article-title":"Effectiveness and safety of sofosbuvir-velpatasvir in patients with cirrhosis associated with genotype 3 hepatitis c infection in xinjiang, China","volume":"15","author":"Abulitifu","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/jvh.12652","article-title":"A molecular transmission network of recent hepatitis c infection in people with and without HIV: implications for targeted treatment strategies","volume":"24","author":"Bartlett","year":"2017","journal-title":"J. Viral Hepat."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis c virus genotype from punjab, India: expanding classification of hepatitis c virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jhep.2020.08.006","article-title":"Hepatic benefits of HCV cure","volume":"73","author":"Calvaruso","year":"2020","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/infdis\/jiv542","article-title":"Accurate genetic detection of hepatitis c virus transmissions in outbreak settings","volume":"213","author":"Campo","year":"2016","journal-title":"J. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1038\/emi.2017.77","article-title":"Hepatitis c virus genotypes and subtypes circulating in mainland China","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1080\/22221751.2021.1978822","article-title":"HIV-1 CRF07_BC transmission dynamics in China: two decades of national molecular surveillance","volume":"10","author":"Ge","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.3748\/wjg.v21.i13.3904","article-title":"Interferon-\u03bb3 polymorphisms in pegylated-interferon-\u03b1 plus ribavirin therapy for genotype-2 chronic hepatitis c","volume":"21","author":"Ishiguro","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0029721","DOI":"10.1128\/Spectrum.00297-21","article-title":"Characterization of a novel hepatitis c subtype, 6xj, and its consequences for direct-acting antiviral treatment in yunnan, China","volume":"9","author":"Jia","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7395506","article-title":"Geographic distribution of HCV genotypes and efficacy of direct-acting antivirals in chronic HCV-infected patients in north and northeast China: a real-world multicenter study","volume":"2022","author":"Li","year":"2022","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/14787210.2019.1675509","article-title":"How would China achieve WHO\u2019s target of eliminating HCV by 2030","volume":"17","author":"Li","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2022.100071","article-title":"Phylogenetic signature and prevalence of natural resistance-associated substitutions for hepatitis c virus genotypes 3a and 3b in southwestern China","volume":"8","author":"Liu","year":"2022","journal-title":"J. Virus Erad."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.1128\/JVI.00414-14","article-title":"Migration patterns of hepatitis c virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities","volume":"88","author":"Lu","year":"2014","journal-title":"J. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.meegid.2015.04.017","article-title":"A molecular phylogenetics-based approach for identifying recent hepatitis c virus transmission events","volume":"33","author":"Olmstead","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/jmv.24356","article-title":"Subtype distribution of hepatitis c virus in jiangsu, China","volume":"88","author":"Qi","year":"2016","journal-title":"J. Med. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/s12879-021-06577-8","article-title":"The distribution of hepatitis c virus infection in shanghai, China: a time-spatial study","volume":"21","author":"Qu","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39080913.x","article-title":"Hepatitis c virus infection in blood donors in the people\u2019s republic of China","volume":"39","author":"Shi","year":"1999","journal-title":"Transfusion"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0163062","DOI":"10.1371\/journal.pone.0163062","article-title":"HCV diversity among Chinese and Burmese IDUs in dehong, yunnan, China","volume":"11","author":"Wan","year":"2016","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00705-019-04260-7","article-title":"Hepatitis c virus 3b strains in injection drug users in guangdong province, China, may have originated in yunnan province","volume":"164","author":"Wang","year":"2019","journal-title":"Arch. Virol."},{"key":"B21","unstructured":"World health organization. hepatitis c2022"},{"key":"B22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000445626","article-title":"A unique pattern of HCV genotype distribution on hainan island in China revealed by evolutionary analysis","volume":"39","author":"Wu","year":"2016","journal-title":"Cell Physiol. Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/jmv.21204","article-title":"The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in yunnan, China","volume":"80","author":"Xia","year":"2008","journal-title":"J. Med. Virol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/v14071514","article-title":"The transmission route and selection pressure in HCV subtype 3a and 3b Chinese infections: evolutionary kinetics and selective force analysis","volume":"14","author":"Xu","year":"2022","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.meegid.2013.08.014","article-title":"A panel of 16 full-length HCV genomes was characterized in China belonging to genotypes 1-6 including subtype 2f and two novel genotype 6 variants","volume":"20","author":"Xu","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5812\/hepatmon.857","article-title":"Changing pattern of clinical epidemiology on hepatitis c virus infection in southwest china","volume":"12","author":"Yan","year":"2012","journal-title":"Hepat. Mon."},{"key":"B27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2019.11.019","article-title":"Identification of a new HCV subtype 6xi among chronic hepatitis c patients in yunnan, China","volume":"80","author":"Yue","year":"2020","journal-title":"J. Infect."},{"key":"B28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12985-017-0710-z","article-title":"Hepatitis c virus in mainland China with an emphasis on genotype and subtype distribution","volume":"14","author":"Zhang","year":"2017","journal-title":"Virol. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e82598","DOI":"10.1371\/journal.pone.0082598","article-title":"Hepatitis c virus genotype diversity among intravenous drug users in yunnan province, southwestern China","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/jvh.12677","article-title":"Population dynamics of hepatitis c virus subtypes in injecting drug users on methadone maintenance treatment in China associated with economic and health reform","volume":"24","author":"Zhou","year":"2017","journal-title":"J. Viral Hepat."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1092936\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T05:12:17Z","timestamp":1689052337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1092936\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":29,"alternative-id":["10.3389\/fcimb.2023.1092936"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1092936","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"article-number":"1092936"}}